Silvant Capital Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-2,883
Closed -$265K – 336
2021
Q2
$265K Hold
2,883
– – 0.04% 169
2021
Q1
$351K Hold
2,883
– – 0.06% 147
2020
Q4
$442K Hold
2,883
– – 0.08% 134
2020
Q3
$373K Hold
2,883
– – 0.07% 126
2020
Q2
$324K Hold
2,883
– – 0.06% 135
2020
Q1
$219K Hold
2,883
– – 0.05% 147
2019
Q4
$293K Hold
2,883
– – 0.05% 150
2019
Q3
$294K Hold
2,883
– – 0.06% 145
2019
Q2
$334K Hold
2,883
– – 0.06% 145
2019
Q1
$303K Hold
2,883
– – 0.05% 153
2018
Q4
$325K Buy
2,883
+1,049
+57% +$129K 0.07% 141
2018
Q3
$297K Hold
1,834
– – 0.04% 162
2018
Q2
$218K Buy
+1,834
New +$225K 0.03% 189

Other funds holding PRLB

Silvant Capital Management's PRLB Position: Q3 2021 in Review

Silvant Capital Management sold out of Protolabs (PRLB) in Q3 2021, closing a stake of 2,883 shares — an estimated $265K sold.

Silvant Capital Management first reported a position in PRLB in Q2 2018 and held it in 13 quarters. The position peaked at $442K in Q4 2020. 263 funds tracked by Wall St. Rank hold PRLB as of Q3 2021.

  • Silvant Capital Management reported no remaining Protolabs position as of Q3 2021 after selling out during the quarter.
  • Silvant Capital Management sold 2,883 Protolabs shares in Q3 2021, an estimated $265K.
  • Silvant Capital Management first reported a position in Protolabs in Q2 2018 and held it in 13 quarters.
  • Silvant Capital Management's Protolabs position peaked at $442K in Q4 2020.
  • 263 funds tracked by Wall St. Rank held Protolabs as of Q3 2021.

Based on Silvant Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.